Czy terapia LDN poprawi jakość życia pacjentów z fibromialgią? (in Polish) (News)

Will LDN therapy improve the quality of life of patients with fibromyalgia? (in Polish) (News)

05 May 2023

In Poland, fibromyalgia is diagnosed based on the ACR (American College of Rheumatology) criteria, which require the presence of pain in at least 11 out of 18 characteristic pain points. In addition to the pain and fatigue that occur in this disease, fibromyalgia can also cause sleep disturbances, mood disorders, and problems with memory and concentration. Low-dose naltrexone (LDN) is a type of therapy that has been gaining more and more interest among many doctors in recent years as a potential treatment option for various diseases, including long-COVID, supportive treatment of fertility disorders, and fibromyalgia. The results of several recently published scientific papers have shown that LDN may be effective in reducing the symptoms of fibromyalgia, including pain, fatigue and sleep disturbances.